Literature DB >> 31311303

Bempedoic acid and ezetimibe - better together.

Safi U Khan1, Erin D Michos2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31311303      PMCID： PMC7203625          DOI： 10.1177/2047487319864672

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  11 in total

Review 1.  Effective low-density lipoprotein-lowering therapy: Implementation in clinical practice.

Authors:  David Sinning; Ulf Landmesser
Journal:  Eur J Prev Cardiol       Date:  2017-06       Impact factor: 7.804

2.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

3.  Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

Authors:  Paul M Ridker; Jean MacFadyen; Peter Libby; Robert J Glynn
Journal:  Am J Cardiol       Date:  2010-06-10       Impact factor: 2.778

4.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 5.  A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.

Authors:  Safi U Khan; Swapna Talluri; Haris Riaz; Hammad Rahman; Fahad Nasir; Irbaz Bin Riaz; Sudhakar Sattur; Haitham Ahmed; Edo Kaluski; Richard Krasuski
Journal:  Eur J Prev Cardiol       Date:  2018-03-23       Impact factor: 7.804

6.  Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.

Authors:  Kausik K Ray; Harold E Bays; Alberico L Catapano; Narendra D Lalwani; LeAnne T Bloedon; Lulu R Sterling; Paula L Robinson; Christie M Ballantyne
Journal:  N Engl J Med       Date:  2019-03-14       Impact factor: 91.245

Review 7.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Authors:  Michael G Silverman; Brian A Ference; Kyungah Im; Stephen D Wiviott; Robert P Giugliano; Scott M Grundy; Eugene Braunwald; Marc S Sabatine
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

8.  Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.

Authors:  Brian A Ference; John J P Kastelein; Henry N Ginsberg; M John Chapman; Stephen J Nicholls; Kausik K Ray; Chris J Packard; Ulrich Laufs; Robert D Brook; Clare Oliver-Williams; Adam S Butterworth; John Danesh; George Davey Smith; Alberico L Catapano; Marc S Sabatine
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

Review 9.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Brian A Ference; Henry N Ginsberg; Ian Graham; Kausik K Ray; Chris J Packard; Eric Bruckert; Robert A Hegele; Ronald M Krauss; Frederick J Raal; Heribert Schunkert; Gerald F Watts; Jan Borén; Sergio Fazio; Jay D Horton; Luis Masana; Stephen J Nicholls; Børge G Nordestgaard; Bart van de Sluis; Marja-Riitta Taskinen; Lale Tokgözoglu; Ulf Landmesser; Ulrich Laufs; Olov Wiklund; Jane K Stock; M John Chapman; Alberico L Catapano
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

10.  Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.

Authors:  Christie M Ballantyne; Ulrich Laufs; Kausik K Ray; Lawrence A Leiter; Harold E Bays; Anne C Goldberg; Erik Sg Stroes; Diane MacDougall; Xin Zhao; Alberico L Catapano
Journal:  Eur J Prev Cardiol       Date:  2019-07-29       Impact factor: 7.804
View more
  3 in total

1.  New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.

Authors:  Sean Paul Gaine; Renato Quispe; Jaideep Patel; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2022-06-25

Review 2.  Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside.

Authors:  Anandita Agarwala; Renato Quispe; Anne C Goldberg; Erin D Michos
Journal:  Drug Des Devel Ther       Date:  2021-05-10       Impact factor: 4.162

Review 3.  Clinical approach to the inflammatory etiology of cardiovascular diseases.

Authors:  Massimiliano Ruscica; Alberto Corsini; Nicola Ferri; Maciej Banach; Cesare R Sirtori
Journal:  Pharmacol Res       Date:  2020-05-20       Impact factor: 7.658
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.